Breaking News Instant updates and real-time market news.

PIR

Pier 1 Imports

$3.54 /

-0.21 (-5.60%)

14:19
02/17/20
02/17
14:19
02/17/20
14:19

Pier 1 Imports enters plan support agreement, announces sale process

Pier 1 Imports announced that it has entered into a Plan Support Agreement with a majority of its term loan lenders and is pursuing a sale of the company. To facilitate an orderly sale process and implement the PSA, the company and its subsidiaries have commenced voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Virginia. The company also intends to use this process to complete the previously announced closure of up to 450 store locations, which includes the closure of all its stores in Canada. To date, the company has closed or initiated going-out-business sales at over 400 locations. The company is also in the process of closing two distribution centers to reflect its revised store footprint. Pier 1 intends to conduct a court-supervised sale process and complete the sale through a Chapter 11 plan. Pier 1 expects that the deadline to submit qualified binding bids will be on or around March 23, 2020, subject to procedures to be approved by the court. In connection with its plans to close all its stores in Canada, Pier 1 is also commencing proceedings in Canada.

PIR Pier 1 Imports
$3.54 /

-0.21 (-5.60%)

04/24/19 Morgan Stanley
At Home could double market share, triple sales by 2028, says Morgan Stanley
03/21/19 Gordon Haskett
Gordon Haskett shakes up retailer rankings with six upgrades, three downgrades
03/21/19 Gordon Haskett
Pier 1 Imports downgraded to Underperform at Gordon Haskett

TODAY'S FREE FLY STORIES

Upgrade
Infineon upgraded to Buy from Hold at Societe Generale » 20:56
04/05/20
04/05
20:56
04/05/20
20:56
IFNNY

Infineon

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Gannett downgraded to Sell from Neutral at Citi » 20:51
04/05/20
04/05
20:51
04/05/20
20:51
GCI

Gannett

$0.81 /

-0.155 (-16.14%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Cemex downgraded to Neutral from Outperform at Credit Suisse » 20:49
04/05/20
04/05
20:49
04/05/20
20:49
CX

Cemex

$1.73 /

-0.145 (-7.73%)

Credit Suisse downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Designer Brands downgraded to Neutral from Positive at Susquehanna » 20:48
04/05/20
04/05
20:48
04/05/20
20:48
DBI

Designer Brands

$3.81 /

-0.29 (-7.07%)

Susquehanna analyst Sam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Steven Madden downgraded to Neutral from Positive at Susquehanna » 20:48
04/05/20
04/05
20:48
04/05/20
20:48
SHOO

Steven Madden

$20.51 /

-0.48 (-2.29%)

Susquehanna analyst Sam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: Top five weekend stock stories » 20:09
04/05/20
04/05
20:09
04/05/20
20:09
GILD

Gilead

$78.22 /

+1.255 (+1.63%)

, BA

Boeing

$124.59 /

+1.38 (+1.12%)

, FB

Facebook

$154.19 /

-3.92 (-2.48%)

, TWTR

Twitter

$23.08 /

+0.07 (+0.30%)

, GOOG

Alphabet

$1,097.93 /

-25.87 (-2.30%)

, GOOGL

Alphabet Class A

$1,092.51 /

-24.78 (-2.22%)

, UAL

United Airlines

$22.89 /

-0.53 (-2.26%)

, CMCSA

Comcast

$33.94 /

-0.43 (-1.25%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

, T

AT&T

$27.46 /

-1.305 (-4.54%)

, VZ

Verizon

$54.72 /

-0.52 (-0.94%)

, ABT

Abbott

$79.50 /

+0.075 (+0.09%)

, CVX

Chevron

$75.15 /

-1.07 (-1.40%)

, HRL

Hormel Foods

$48.37 /

+0.72 (+1.51%)

, JNJ

Johnson & Johnson

$134.13 /

+1.05 (+0.79%)

, KMB

Kimberly-Clark

$130.02 /

+0.58 (+0.45%)

, MDT

Medtronic

$86.17 /

+0.02 (+0.02%)

, PG

Procter & Gamble

$115.10 /

+0.68 (+0.59%)

, TROW

T. Rowe Price

$95.02 /

-2.13 (-2.19%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Gilead Sciences (GILD) said it is donating 1.5M doses of its experimental anti-coronavirus drug remdesivir, which could treat 140,000 patients. In an open letter, Chairman and CEO Daniel O'Day said that the drug will be offered for compassionate use, expanded access and clinical trials, and will treat patients with severe symptoms. "Our existing supply, including finished product ready for distribution as well as investigational medicine in the final stages of production, amounts to 1.5 million individual doses. Depending on the optimal duration of treatment, which is something we are studying in clinical trials, this supply could equate to well over 140,000 treatment courses for patients. [...] Gilead is providing the entirety of this existing supply at no cost, to treat patients with the most severe symptoms of COVID-19. The 1.5 million individual doses are available for compassionate use, expanded access and clinical trials and will be donated for broader distribution following any potential future regulatory authorizations. These doses are for treating patients with severe symptoms, through daily intravenous infusions in a hospital setting. Having a potential treatment in our hands comes with significant responsibility." 2. Boeing (BA) announced that it is extending the temporary suspension of production operations at all Puget Sound area and Moses Lake sites until further notice. "These actions are being taken in light of the company's continuing focus on the health and safety of employees, current assessment of the spread of COVID-19 in Washington state, the reliability of the supply chain and additional recommendations from government health authorities," the plane maker said in a statement Sunday night. 3. Across the media landscape, advertising is disappearing, one more casualty of the global economic shutdown, and new technology won't be a savior as this is an equal-opportunity problem across print, TV, digital, radio, and outdoor advertising, Eric Savitz wrote in this week's edition of Barron's. Even the most prominent ad buyers lack reasons, and often the means, to buy ads, the author notes, while many of the small and medium-size businesses that buy online ads are struggling to stay solvent. Both Facebook (FB) and Twitter (TWTR) have already warned that they will take a hit from the downturn, and Alphabet's Google (GOOGL) no doubt is seeing the same effects, but so far hasn't discussed the matter, the publication adds. 4. United Airlines (UAL) is cutting nearly 90% of its New York-area flying, as public health officials predicted that the city will reach the peak of its novel coronavirus outbreak in the coming days, The Wall Street Journal's Alison Sider reported. The airline said the reductions set to remain in place for at least three weeks will mean substantially fewer employees will need to show up each day, though workers will continue to receive pay and benefits, the author noted. 5. Comcast (CMCSA), AT&T (T), Verizon (VZ), Abbott Laboratories (ABT), Chevron (CVX), Hormel Foods (HRL), Johnson & Johnson (JNJ), Kimberly-Clark (KMB), Medtronic (MDT), Procter & Gamble (PG), and T. Rowe Price (TROW) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Konecranes upgraded to Neutral from Sell at Goldman Sachs » 20:06
04/05/20
04/05
20:06
04/05/20
20:06
KNCRF

Konecranes

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Adyen initiated with a Buy at Jefferies » 19:58
04/05/20
04/05
19:58
04/05/20
19:58
ADYYF

Adyen

$0.00 /

+ (+0.00%)

Jefferies analyst Julian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
COVID-19 'a tailwind' for restaurant software, Par to take share, says Jefferies » 19:55
04/05/20
04/05
19:55
04/05/20
19:55
PAR

Par Technology

$10.96 /

-1.04 (-8.67%)

Jefferies analyst Samad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Ingenico initiated with a Hold at Jefferies » 19:52
04/05/20
04/05
19:52
04/05/20
19:52
INGIY

Ingenico

$0.00 /

+ (+0.00%)

, WWLNF

Worldline

$0.00 /

+ (+0.00%)

Jefferies analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Worldline initiated with a Buy at Jefferies » 19:50
04/05/20
04/05
19:50
04/05/20
19:50
WWLNF

Worldline

$0.00 /

+ (+0.00%)

, INGIY

Ingenico

$0.00 /

+ (+0.00%)

Jefferies analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Network International initiated with a Hold at Jefferies » 19:47
04/05/20
04/05
19:47
04/05/20
19:47
NWITY

Network International

$0.00 /

+ (+0.00%)

Jefferies analyst Julian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Boeing extends Seattle production suspension due to COVID-19 » 18:10
04/05/20
04/05
18:10
04/05/20
18:10
BA

Boeing

$124.59 /

+1.38 (+1.12%)

Boeing announced that it…

Boeing announced that it is extending the temporary suspension of production operations at all Puget Sound area and Moses Lake sites until further notice. "These actions are being taken in light of the company's continuing focus on the health and safety of employees, current assessment of the spread of COVID-19 in Washington state, the reliability of the supply chain and additional recommendations from government health authorities," the plane maker said in a statement Sunday night. During the suspension, Boeing said it will continue to implement additional health and safety measures at its facilities to protect employees. These measures include new visual cues to encourage physical distancing, more frequent and thorough cleaning of work and common areas and staggering shift times to reduce the flow of employees arriving and departing work, among many other improvements. It added, "As the suspension of operations continues, Boeing will monitor government guidance and actions on COVID-19 and associated impact on all company operations. Boeing sites that remain open are being monitored and assessed on a daily basis."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
3M responds to reporting on alleged seizure of N95 respirator shipments » 17:30
04/05/20
04/05
17:30
04/05/20
17:30
MMM

3M

$133.90 /

-3.96 (-2.87%)

3M issued the following…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
GM offers blueprint for face masks to auto parts suppliers, CNBC reports » 17:23
04/05/20
04/05
17:23
04/05/20
17:23
GM

General Motors

$18.03 /

-0.15 (-0.83%)

General Motors is…

General Motors is encouraging and empowering its suppliers to assist in production of medical face masks for frontline workers amid the coronavirus pandemic, CNBC's Michael Wayland reports. In a note to the suppliers, Shilpan Amin, GM's vice president of global purchasing and supply chain, said it is making the automaker's step-by-step manufacturing plans for the personal protective equipment available to any company willing to join in the cause. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Livent upgraded to Market Perform from Underperform at BMO Capital » 16:17
04/05/20
04/05
16:17
04/05/20
16:17
LTHM

Livent

$4.73 /

+0.125 (+2.71%)

, ALB

Albemarle

$52.72 /

-0.92 (-1.72%)

, SQM

SQM

$21.07 /

-0.96 (-4.36%)

BMO Capital analyst Joel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Amazon, test makers in contact for potential employees' screenings, Reuters says » 15:52
04/05/20
04/05
15:52
04/05/20
15:52
AMZN

Amazon.com

$1,905.33 /

-11.69 (-0.61%)

, ABT

Abbott

$79.50 /

+0.075 (+0.09%)

, TMO

Thermo Fisher

$281.84 /

-5.125 (-1.79%)

Amazon (AMZN) has been in…

Amazon (AMZN) has been in contact with the CEOs of two coronavirus test makers as it considers how to screen its staff and reduce the risk of infection at its warehouses, Reuters' Jeffrey Dastin and Krystal Hu report, citing internal meeting notes. The chief executives of Abbott Laboratories (ABT) and Thermo Fisher Scientific (TMO) have told Amazon they would like to work with the e-commerce company, though the U.S. government is taking up all of their testing capacity at present, the notes said. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Capital One not using CFTC waiver related to oil lending, Reuters says » 15:28
04/05/20
04/05
15:28
04/05/20
15:28
COF

Capital One

$42.27 /

-1.72 (-3.91%)

Capital One said it would…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Zoom CEO tells WSJ 'I really messed up' on security » 15:26
04/05/20
04/05
15:26
04/05/20
15:26
ZM

Zoom Video

$128.08 /

+6.24 (+5.12%)

In the space of a month,…

In the space of a month, Zoom's videoconferencing business Eric Yuan founded nine years ago has gone from an enterprise-software provider little known outside the business world to a near-ubiquitous social lifeline for homebound Americans and, most recently, the subject of complaints about privacy problems and harassment on its platform, The Wall Street Journal's Aaron Tilley and Robert McMillan report. The whiplash has left Yuan trying to appease upset users and figure out what went wrong-and rethinking a company culture that for nearly a decade was focused on ease of use. "'If we mess up again, it's done,' I thought a lot last night," he told The Wall Street Journal in an interview Friday. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Trump threatens tariffs on oil imports to 'protect' energy workers, Reuters says » 15:18
04/05/20
04/05
15:18
04/05/20
15:18
BP

BP

$24.72 /

-1.32 (-5.07%)

, COP

ConocoPhillips

$32.90 /

-0.945 (-2.79%)

, TOT

Total

$35.76 /

-3.85 (-9.72%)

, XOM

Exxon Mobil

$39.20 /

-1.19 (-2.95%)

, CVX

Chevron

$75.15 /

-1.07 (-1.40%)

, RDS.A

Royal Dutch Shell

$36.24 /

-2.78 (-7.12%)

President Donald Trump…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Gilead to donate experimental COVID-19 drug Remdesivir » 15:13
04/05/20
04/05
15:13
04/05/20
15:13
GILD

Gilead

$78.22 /

+1.255 (+1.63%)

Gilead Sciences said it…

Gilead Sciences said it is donating 1.5M doses of its experimental anti-coronavirus drug remdesivir, which could treat 140,000 patients. In an open letter, Chairman and CEO Daniel O'Day said that the drug will be offered for compassionate use, expanded access and clinical trials, and will treat patients with severe symptoms. "In addition to the expanded access programs, we continue to provide remdesivir on an individual compassionate use basis for children and pregnant women. More than 1,700 patients have now been treated through these programs. [...] As soon as we knew that remdesivir may have potential in treating the novel coronavirus, our teams began to establish a supply chain for large-scale production. Then, as now, there were many unknowns including how long the outbreak would last, at what scale and whether remdesivir is a safe and effective treatment for COVID-19. We made the decision to invest and scale up regardless, because if remdesivir was going to be needed for patients, we had to be ready. In the space of two months, we have significantly increased our available supply of remdesivir using the inventory of active pharmaceutical ingredients we already had on hand. Our existing supply, including finished product ready for distribution as well as investigational medicine in the final stages of production, amounts to 1.5 million individual doses. Depending on the optimal duration of treatment, which is something we are studying in clinical trials, this supply could equate to well over 140,000 treatment courses for patients.[...] Gilead is providing the entirety of this existing supply at no cost, to treat patients with the most severe symptoms of COVID-19. The 1.5 million individual doses are available for compassionate use, expanded access and clinical trials and will be donated for broader distribution following any potential future regulatory authorizations. These doses are for treating patients with severe symptoms, through daily intravenous infusions in a hospital setting. Having a potential treatment in our hands comes with significant responsibility. Providing our existing supplies at no charge is the right thing to do, to facilitate access to patients as quickly as possible and in recognition of the public emergency posed by this pandemic." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Luckin Coffee business to continue amid financial fraud probe, Reuters reports » 14:56
04/05/20
04/05
14:56
04/05/20
14:56
LK

Luckin Coffee

$5.37 /

-0.98 (-15.43%)

, SBUX

Starbucks

$63.09 /

-1.89 (-2.91%)

Luckin Coffee (LK) said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Gaps in Amazon COVID-19 response fuel warehouse workers demands, NYTimes says » 14:51
04/05/20
04/05
14:51
04/05/20
14:51
AMZN

Amazon.com

$1,905.33 /

-11.69 (-0.61%)

As millions of Americans…

As millions of Americans heed government orders to hunker down, ordering food and medicines and books and puzzle boards for home delivery, many of Amazon's 400,000 warehouse workers have stayed on the job, fulfilling the crushing demands of a country suddenly working and learning from home, The New York Times' Karen Weise and Kate Conger report. For all of its high-tech sophistication, Amazon's vast e-commerce business is dependent on an army of workers operating in warehouses they now fear are contaminated with the coronavirus, the authors note. While Amazon's workers are not unionized, the crisis has given workplace organizers unexpected leverage to demand better pay, better sick leave and more of a voice in how the company is run. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
PAVmed to host business news update conference call » 14:49
04/05/20
04/05
14:49
04/05/20
14:49
PAVM

PAVmed

$1.79 /

-0.09 (-4.79%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Conference/Events
U.S. Gold to hold investor update webcast » 14:46
04/05/20
04/05
14:46
04/05/20
14:46
USAU

U.S. Gold

$4.95 /

+0.19 (+3.99%)

President & CEO Karr…

President & CEO Karr provides an update and outlook for the Company on a webcast to be held on April 7 at 11:30 am. Webcast Link

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.